Details of the Drug
General Information of Drug (ID: DML6FI3)
| Drug Name | 
                     Naphthalene Trisulfonate 
                 | 
            ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | 
                                         
                        naphthalene-1,3,6-trisulfonic acid; 86-66-8; 1,3,6-Naphthalenetrisulfonic acid; Naphthalene-1,3,6-trisulphonic acid; CHEBI:32916; 123409-01-8; EINECS 201-690-8; AC1Q6WKO; 6321-17-1; 19437-42-4; SCHEMBL305166; AC1L1I64; CHEMBL1160117; DTXSID9058945; CTK2F6984; ZPBSAMLXSQCSOX-UHFFFAOYSA-N; ZINC1664865; Naphtalene-1,3,6-trisulfonic acid; 3611AC; AKOS015964183; OR51840; AJ-28977; AX8143250; KB-258586; ST50826289; 1,3, -Naphthalenetrisulfonicacid, trisodium salt, hydrate (9CI)
                        
                     
                                     | 
            ||||||||||||||||||||||
| Indication | 
                                                            
  | 
            ||||||||||||||||||||||
| Drug Type | 
                     Small molecular drug 
                 | 
            ||||||||||||||||||||||
| Structure | 
                    ![]()  | 
            ||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 365.3 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | -0.8 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 0 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 9 | ||||||||||||||||||||||
| Chemical Identifiers | 
                        
  | 
                ||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT)  | 
                
                    
  | 
            ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
                    
  | 
            ||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||


